<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02246192</url>
  </required_header>
  <id_info>
    <org_study_id>Sinusprgf</org_study_id>
    <nct_id>NCT02246192</nct_id>
  </id_info>
  <brief_title>Use of Plasma Rich in Growth Factors (PRGF) in Pilonidal Sinus Excision</brief_title>
  <official_title>Application of PRGF (Plasma Rich in Growth Factors) to Reduce the Healing Time After Pilonidal Sinus Excision. A Randomized 5-years Prospective Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Quiron Sagrado Corazon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Quiron Sagrado Corazon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of plasma rich in growth factors in wound excision pilonidal sinus could improve the&#xD;
      healing process of the wound, when compared with the usual technique of daily local healing.&#xD;
      The investigators propose the objective of evaluating the efficacy of intra- and&#xD;
      postoperative application of plasma rich in growth factors, to reduce healing time and&#xD;
      complications, arising from its removal, compared to the standard surgical treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      prospective randomized control trial, comparing PRGF application vs daily local care(betadine&#xD;
      +saline) in sinus pilonidal wound excision. PRGF is extracted from de patient blood and&#xD;
      infiltrated in the pilonidal wound every week. this treatment is compared with betadine and&#xD;
      saline wound care in terms of wound healing time, pospoperative pain and other complications.&#xD;
&#xD;
      this study try to keeps the advantages of using open technique for pilonidal desease( low&#xD;
      recurrence rate and surgical site infections) and improving the disadvantages (high wound&#xD;
      healing time and postperative pain with wore quality of life) when it´s compared with direct&#xD;
      closure or flap techniques.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>healing time(days) of pilonidal sinus wound excision</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>1 month</time_frame>
    <description>using VAS to assess postoperative pain</description>
  </secondary_outcome>
  <other_outcome>
    <measure>postoperative bleeding</measure>
    <time_frame>1 week</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>surgical site infection rate</measure>
    <time_frame>1 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>sinus recurrence rate</measure>
    <time_frame>4 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>this measure is assessed asking the possibility of standing in Water closet(WC) or walking correctly.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Pilonidal Sinus</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sinus pilonidal excision and standard cares</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PRGF group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sinus pilonidal excision+ PRGF</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sinus pilonidal excision+ PRGF</intervention_name>
    <description>open sinus pilonidal excision and plasma rich grow factor infiltration intra and postoperatively</description>
    <arm_group_label>PRGF group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sinus pilonidal excision and standard cares</intervention_name>
    <description>sinus pilonidal excision and postoperative standard care with povidone daily</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients among 13 and 65 years old&#xD;
&#xD;
          -  Possibility of observation during the follow-up period&#xD;
&#xD;
          -  Patients who have read and signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Abscessed pilonidal sinus&#xD;
&#xD;
          -  Recurrent pilonidal sinus&#xD;
&#xD;
          -  Patients treated with immunosuppressive drugs or anticoagulants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan Bellido Luque</last_name>
    <role>Principal Investigator</role>
    <affiliation>Quirón Sagrado Corazón Hospital, Seville, Spain</affiliation>
  </overall_official>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>August 13, 2014</study_first_submitted>
  <study_first_submitted_qc>September 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2014</study_first_posted>
  <last_update_submitted>March 18, 2015</last_update_submitted>
  <last_update_submitted_qc>March 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Quiron Sagrado Corazon</investigator_affiliation>
    <investigator_full_name>Juan Bellido Luque.MD</investigator_full_name>
    <investigator_title>Ph.D</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pilonidal Sinus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

